Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism CD43 inhibitors(JL1 antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
T-Cell Leukemia | Preclinical | CN | - | |
T-Cell Lymphoma | Preclinical | CN | - |